mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.004 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.14 |
0.004 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.004 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.006 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.12 |
0.006 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |